| Application no. and date | 14824658.0 (espacenet) (Federated) (European Patent Register), 20141212 | | Patent/reg. no. and date | DK/EP 3080134, 20180801 | | Publication date | 20161019 | | Priority no. and date | US 201361915937 P, 20131213 | | EP pub. no. and date |
EP 3080134 20161019 | | Effective date | | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | | Applicant ref. no. | P65837DK01 | | Inventor | ZHANG, Beili, 4505 Shorepointe Way
San Diego, CA 92130, US,
KESHAVARZ-SHOKRI, Ali, 4285 Corte Langostino
San Diego, CA 92130, US,
ANDERSON, Corey, 7565 Charmant Drive
Unit 502
San Diego, CA 92122, US,
LITTLER, Benjamin Joseph, 7016 Ivy Street
Carlsbad, CA 92011, US,
Alcacio, Tim Edward, 4708 Lucille Drive
San Diego, CA 92115, US,
HADIDA-RUAH, Sara Sabina, 2356 Torrey Pines Road 16
La Jolla, CA 92037, US,
GOLEC, Julian Marian Charles, Milton Park
Abingdon, Oxfordshire SN7 7QI, GB,
BELMONT, Daniel T., 1 Gershom Drive
Grafton, MA 01536, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/675 (2006.01) , A61P 19/02 (2006.01) , C07F 9/576 (2006.01) | | Title | PRODRUGS AF PYRIDONAMIDER ANVENDELIGE SOM MODULATORER AF NATRIUMKANALER | | Int. application no. | US2014069916 | | Int. publication no. | WO2015089361 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
